Personalized Medicine – Webinars and Online Events
Webinar
Uncovering the Impact of Pharmacogenomics on Precision Medicine
In this webinar, we will explore the ground-breaking role of genetic insights in revolutionizing healthcare.
Webinar
Episode 1: Integrating PCR with Emerging Technologies
On-Demand
In our first episode of the New Frontiers in PCR Technology Series, join an exclusive Ask Me Anything with Professor Mikael Kubista. Discover how PCR is evolving with next-generation sequencing, CRISPR and microfluidics.
Online Event
Advances in Proteomics & Metabolomics 2024
On-Demand
Hear about the latest advancements in translational proteomics and metabolomics. From the molecular mechanisms of disease pathology to the latest technological developments in diagnostics and treatment.
Online Event
Advances in Drug Discovery & Development 2024
On-Demand
This online event is aimed at those working within academia and pharmaceutical drug development, who want to hear from experts across their field. Focus will be given to the latest advances in small molecule drug discovery and development.
Webinar
Ensuring the Clinical Utility of Pharmacogenomic Tests
On-Demand
Pharmacogenomic testing uses a patient’s genome to identify their response to a drug, forming a key part of personalized medicine.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.
Hundreds of clinical pharmacogenomics (PGx) tests are currently available on the market in the United States. With so many tests available, how can you determine that a test is clinically and analytically valid and holds clinical utility?
In this webinar, our expert speaker will outline the ACCE Model Project Framework as a tool for evaluating pharmacogenomic tests, describing the key considerations to take into account when implementing these tests.
You’ll learn how to select the genetic variants to be tested, choose the appropriate genotyping technology and develop laboratory procedures for sample processing and data analysis.
Ask Me Anything
Ask Me Anything: Proteomics
On-Demand
Dr. Yates is a world-renowned proteomics expert whose work has revolutionized the field and his groundbreaking techniques are used by researchers worldwide. But Yates' impact goes beyond his discoveries. A decorated scientist and champion of mass spectrometry research, he also leads the prestigious Journal of Proteome Research.
Online Event
The Landscape of Cancer Research: Advances in Immuno-oncology 2024
On-Demand
Key advances will be highlighted across the field of immuno-oncology. Hear a cross-section of experts discuss their research with a focus on basic research and a broad range of established and novel immunotherapeutics.
Webinar
Population-Level Multiomics for Precision Medicine
On-Demand
Our expert speaker will explore how the findings uncover previously unknown insights into disease biology that can help accelerate the identification of new therapeutic targets and biomarkers.
Online Event
Cell and Gene Therapy 2024
On-Demand
Explore cutting-edge cell and gene therapies at our online symposium on March 20–21. Experts will discuss cancer immunotherapy, gene therapy vectors, stem cells, and precision oncology research.
Webinar
Identifying Biomarkers for IBD Diagnosis and Management
On-Demand
Driving biomarker discovery is key as proteomics emerges as the next frontier in precision medicine.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.
In this webinar, you’ll hear how proteomics technology can enhance the identification of biomarkers for the accurate diagnosis of Crohn’s disease and ulcerative colitis, as well as the identification of biomarkers that predict response to TNF inhibitors and other biologics in patients with IBD.
This webinar will explore how reliable, non-invasive proteomic biomarkers are pivotal for personalized treatment and increasing our knowledge of biological pathways involved in disease. Our expert speaker will also present an assay platform that can measure 11,000 biologically relevant proteins in the search for biomarkers.
Advertisement